Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV

Fig 1

Effect ITPase activity on total adverse events.

The effect of decreased versus normal ITPase activity on the occurrence of total adverse events (grouped by regimens containing tenofovir, abacavir or didanosine and regimens without tenofovir, abacavir or didanosine) is plotted. Odds ratio with 95% confidential interval and matching p-values are displayed. The analyses were conducted with repeated statement, adjusted for cumulative total duration of cART, cumulative duration of purine analogue therapy of all prior regimens and duration of the current regimen.

Fig 1